IGNACIO MARIA
GONZALEZ PINTO ARRILLAGA
Catedrático de Universidad
Hospital Clínico Universitario Lozano Blesa
Zaragoza, EspañaPublicaciones en colaboración con investigadores/as de Hospital Clínico Universitario Lozano Blesa (7)
2019
-
A survey of Heads of Surgery and Residents on accessibility and employment in liver transplant teams in Spain
Cirugia Espanola, Vol. 97, Núm. 10, pp. 560-567
2018
-
Direct-acting antivirals are effective and safe in HCV/HIV-coinfected liver transplant recipients who experience recurrence of hepatitis C: A prospective nationwide cohort study
American Journal of Transplantation, Vol. 18, Núm. 10, pp. 2513-2522
2016
-
Human immunodeficiency virus infection does not worsen prognosis of liver transplantation for hepatocellular carcinoma
Hepatology, Vol. 63, Núm. 2, pp. 488-498
2015
-
Impact of tacrolimus and mycophenolate mofetil regimen vs. a conventional therapy with steroids on cardiovascular risk in liver transplant patients
Clinical Transplantation, Vol. 29, Núm. 8, pp. 667-677
2009
-
A prospective randomized open study in liver transplant recipients: Daclizumab, mycophenolate mofetil, and tacrolimus versus tacrolimus and steroids
Liver Transplantation, Vol. 15, Núm. 11, pp. 1542-1552
2006
-
Corrigendum to "Immunosuppression without steroids in liver transplantation is safe and reduces infection and metabolic complications: Results from a prospective multicenter randomized study" [J Hepatol 44 (2006) 710-716] (DOI:10.1016/j.jhep.2005.12.010)
Journal of Hepatology
-
Immunosuppression without steroids in liver transplantation is safe and reduces infection and metabolic complications: Results from a prospective multicenter randomized study
Journal of Hepatology, Vol. 44, Núm. 4, pp. 710-716